The proximal gastric pouch invariably contains acid-producing parietal cells in Roux-en-Y gastric bypass

Obesity Surgery

Volumn 15, Issue 6, 2005, Pages 771-777

  Siilin, Helene ^a   Wanders, Alkwin ^b   Gustavsson, Sven ^a   Sundbom, Magnus ^a,b  

^a Department of Surgery ^*  (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Gastric acid; Gastric bypass; Morbid obesity; Parietal cells; Stomach

Indexed keywords

ARTICLE; BODY MASS; CLINICAL ARTICLE; DIGESTION; ESOPHAGUS MUCOSA; FEMALE; GASTROJEJUNOSTOMY; GASTROSTOMY; HISTOLOGY; HUMAN; MALE; MORBID OBESITY; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; STAPLER; STOMACH ACID; STOMACH BIOPSY; STOMACH BYPASS; STOMACH FUNDUS; STOMACH PARIETAL CELL; STOMACH POUCH; STOMACH ULCER; SURGICAL RISK; SURGICAL TECHNIQUE; SUTURE; TREATMENT INDICATION;

EID: 21344441666     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/0960892054222849     Document Type: Article

References (31)

1. Mason EE, Ito C. Gastric bypass in obesity. Surg Clin North Am 1967; 47: 1345-51.
2. Capella JF, Capella RF. The weight reduction operation of choice: vertical banded gastroplasty or gastric bypass? Am J Surg 1996; 171: 74-9.
3. Wittgrove AC, Clark GW, Schubert KR. Laparoscopic gastric bypass, Roux-en-Y: technique and results in 75 patients with 3-30 months follow-up. Obes Surg 1996; 6: 500-4.
4. Sapala JA, Wood MH, Sapala MA et al. The micropouch gastric bypass: technical considerations in primary and revisionary operations. Obes Surg 2001; 11: 3-17.
5. Jones KB, Jr. Bariatric surgery - where do we go from here? Int Surg 2004; 89: 51-7.
6. Sugerman HJ, Kellum JM, Engle KM et al. Gastric bypass for treating severe obesity. Am J Clin Nutr 1992; 55 (Suppl 2): 560S-566S.
7. Cowan GS, Jr., Buffington CK. Significant changes in blood pressure, glucose, and lipids with gastric bypass surgery. World J Surg 1998; 22: 987-92.
8. Fobi MA, Lee H, Felahy B et al. Choosing an operation for weight control, and the transected banded gastric bypass. Obes Surg 2005; 15: 114-21.
9. Capella JF, Capella RF. Castro-gastric fistulas and marginal ulcers in gastric bypass procedures for weight reduction. Obes Surg 1999; 9: 22-7; discussion 28.
10. Printen KJ, Scott D, Mason EE. Stomal ulcers after gastric bypass. Arch Surg 1980; 115: 525-7.
11. Mason EE, Munns JR, Kealey GP et al. Effect of gastric bypass on gastric secretion. Am J Surg 1976; 131: 162-8.
12. MacLean LD, Rhode BM, Nohr C et al. Stomal ulcer after gastric bypass. J Am Coll Surg 1997; 185: 1-7.
13. Jordan JH, Hocking MP, Rout WR et al. Marginal ulcer following gastric bypass for morbid obesity. Am Surg 1991; 57: 286-8.
14. Kilgore SP, Ormsby AH, Gramlich TL et al. The gastric cardia: fact or fiction? Am J Gastroenterol 2000; 95: 921-4.
15. Chandrasoma PT, Der R, Ma Y et al. Histology of the gastroesophageal junction: an autopsy study. Am J Surg Pathol 2000; 24: 402-9.
16. Derdoy JJ, Bergwerk A, Cohen H et al. The gastric cardia: to be or not to be? Am J Surg Pathol 2003; 27: 499-504.
17. Griffen WO Jr, Young VL, Stevenson CC. A prospective comparison of gastric and jejunoileal bypass procedures for morbid obesity. Ann Surg 1977; 186: 500-9.
18. Torres JC, Oca CF, Garrison RN. Gastric bypass: Roux-en-Y gastrojejunostomy from the lesser curvature. South Med J 1983; 76: 1217-21.
19. Mason EE. Vertical banded gastroplasty for obesity. Arch Surg 1982; 117: 701-6.
20. International Federation for the Surgery of Obesity. Statement on morbid obesity and its treatment. Obes Surg 1997; 7: 40-1.
21. Sundbom M, Gustavsson S. Randomized clinical trial of hand-assisted laparoscopic versus open Roux-en-Y gastric bypass for the treatment of morbid obesity. Br J Surg 2004; 91: 418-23.
22. Hung PD, Schubert ML, Mihas AA. Zollinger-Ellison syndrome. Curr Treat Options Gastroenterol 2003; 6: 163-70.
23. Robinson M. Review article: pH, healing and symptom relief with rabeprazole treatment in acid-related disorders. Aliment Pharmacol Ther 2004; 20 (Suppl 6): 30-7.
24. Capella JF, Capella RF. An assessment of vertical banded gastroplasty-Roux-en-Y gastric bypass for the treatment of morbid obesity. Am J Surg 2002; 183: 117-23.
25. Sapala JA, Wood MH, Sapala MA et al. Marginal ulcer after gastric bypass: a prospective 3-year study of 173 patients. Obes Surg 1998; 8: 505-16.
26. Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 2002; 359 (9300): 14-22.
27. Wallace JL. Pathogenesis of NSAID-induced gastroduodenal mucosal injury. Best Pract Res Clin Gastroenterol 2001; 15: 691-703.
28. Janssen M, Dijkmans BA, Vandenbroucke JP et al. Achlorhydria does not protect against benign upper gastrointestinal ulcers during NSAID use. Dig Dis Sci 1994; 39: 362-5.
29. Arroyo MT, Forne M, de Argila CM et al. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe. Helicobacter 2004; 9: 249-54.
30. Sundbom M, Nyman R, Hedenstrom H et al. Investigation of the excluded stomach after Roux-en-Y gastric bypass. Obes Surg 2001; 11: 25-7.
31. Braley SC, Nguyen NT, Wolfe BM. Late gastrointestinal hemorrhage after gastric bypass. Obes Surg 2002; 12: 404-7.